# Comparison of Boric Acid vs. Terconazole in Treatment of RVVC

> **NCT04208555** · NA · UNKNOWN · sponsor: **Hatem AbuHashim** · enrollment: 76 (estimated)

## Conditions studied

- Vulvovaginal Candidiasis

## Interventions

- **DRUG:** Boric Acid Vaginal Suppository
- **DRUG:** Terconazole Vaginal Suppository

## Key facts

- **NCT ID:** NCT04208555
- **Lead sponsor:** Hatem AbuHashim
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-01-15
- **Primary completion:** 2021-02-28
- **Final completion:** 2021-05-31
- **Target enrollment:** 76 (ESTIMATED)
- **Last updated:** 2019-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04208555

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04208555, "Comparison of Boric Acid vs. Terconazole in Treatment of RVVC". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04208555. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*